Semaglutide
Semaglutide is a GLP-1 receptor agonist with 94% amino acid homology to human GLP-1 (CAS 910463-68-2) at 99.5% HPLC-verified purity. Studied for metabolic regulation and insulin secretion pathways.
Semaglutide — Research Summary
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with 94% amino acid sequence homology to human GLP-1. Originally developed to study type 2 diabetes management, it has since become one of the most researched compounds in metabolic science. Research applications include insulin secretion regulation, gastric emptying studies, and appetite signaling pathway analysis. Supplied as a lyophilized powder requiring reconstitution with bacteriostatic water. For laboratory research use only.
Researchers Also Study
For research use only. Not for human or animal consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm these products will be used solely for lawful laboratory research.